This article was originally published in The Gray Sheet
CMS' Physician Group Practice pay-for-performance demonstration realized $9.5 million in savings in its first year and saw significant quality-of-care improvements, the agency announces July 11. The three-year demo, which began in April 2005, has 10 participating practices. First year results were based on 10 quality measures for diabetes care, including blood sugar management and control. For the second year, groups added heart failure and coronary artery disease measures, and for the third year added breast and colorectal cancer screening and hypertension measures. Strategies among the groups, which are rewarded with 80% of the savings they achieve from quality improvements, include health information technology updates and better coordinated care. CMS is considering further expanding the project...
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.